Видео ютуба по тегу Eli Lilly

Eli Lilly climbs after earnings, top analyst talks what's next for pharma giant
Eli Lilly climbs after earnings, top analyst talks what's next for pharma giant
Eil Lilly announces Zepbound to be sold directly to consumers
Eil Lilly announces Zepbound to be sold directly to consumers
Eli Lilly CEO David Ricks: Projecting 32% total growth for company in 2025
Eli Lilly CEO David Ricks: Projecting 32% total growth for company in 2025
The David Rubenstein Show: Eli Lilly CEO Dave Ricks
The David Rubenstein Show: Eli Lilly CEO Dave Ricks
Eli Lilly: Becoming the world's biggest pharmaceutical company 1876-2024
Eli Lilly: Becoming the world's biggest pharmaceutical company 1876-2024
Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing
Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing
Eli Lilly to sell Zepbound directly to consumers without insurance coverage
Eli Lilly to sell Zepbound directly to consumers without insurance coverage
David A Ricks, Chair and Chief Executive Officer of Eli Lilly and Company
David A Ricks, Chair and Chief Executive Officer of Eli Lilly and Company
Inside Lilly's Corporate Center
Inside Lilly's Corporate Center
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
Dave Ricks, CEO of Eli Lilly | The All-In Interview
Dave Ricks, CEO of Eli Lilly | The All-In Interview
Why Work at Eli Lilly and Company?
Why Work at Eli Lilly and Company?
Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared Holz
Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared Holz
Eli Lilly CEO: We have 11 pipeline projects in obesity
Eli Lilly CEO: We have 11 pipeline projects in obesity
Eli Lilly warns about fake weight loss drugs
Eli Lilly warns about fake weight loss drugs
Why Only 3 Companies Make America's Insulin
Why Only 3 Companies Make America's Insulin
Lilly's profit forecast brings relief amid Zepbound miss | REUTERS
Lilly's profit forecast brings relief amid Zepbound miss | REUTERS
Novo Nordisk CEO says firm's obesity pill could launch before Eli Lilly
Novo Nordisk CEO says firm's obesity pill could launch before Eli Lilly